Alert: Major Price Decline (9/30/20)-Windtree Therapeutics Inc (NASDAQ: WINT).


On 9/30/20, Windtree Therapeutics Inc (NASDAQ: WINT) stock suffered a major decline of -10.4%, closing at $5.50. This decline was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months and has declined -20.9% during the last week.


Current PriceTarget Research Rating

WINT’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.

WINT has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. WINT has a slightly negative Appreciation Score of 30 and a very low Power Rating of 11, producing the Lowest Value Trend Rating.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.

About John Lafferty 94415 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.